<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38918517</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2397-3374</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature human behaviour</Title><ISOAbbreviation>Nat Hum Behav</ISOAbbreviation></Journal><ArticleTitle>Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan.</ArticleTitle><Pagination><StartPage>1530</StartPage><EndPage>1544</EndPage><MedlinePgn>1530-1544</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41562-024-01895-8</ELocationID><Abstract><AbstractText>We investigated whether SARS-CoV-2 infection is associated with short- and long-term neuropsychiatric sequelae. We used population-based cohorts from the Korean nationwide cohort (discovery; n&#x2009;=&#x2009;10,027,506) and the Japanese claims-based cohort (validation; n&#x2009;=&#x2009;12,218,680) to estimate the short-term (&lt;30 days) and long-term (&#x2265;30 days) risks of neuropsychiatric outcomes after SARS-CoV-2 infection compared with general population groups or external comparators (people with another respiratory infection). Using exposure-driven propensity score matching, we found that both the short- and long-term risks of developing neuropsychiatric sequelae were elevated in the discovery cohort compared with the general population and those with another respiratory infection. A range of conditions including Guillain-Barr&#xe9; syndrome, cognitive deficit, insomnia, anxiety disorder, encephalitis, ischaemic stroke and mood disorder exhibited a pronounced increase in long-term risk. Factors such as mild severity of COVID-19, increased vaccination against COVID-19 and heterologous vaccination were associated with reduced long-term risk of adverse neuropsychiatric outcomes. The time attenuation effect was the strongest during the first six months after SARS-CoV-2 infection, and this risk remained statistically significant for up to one year in Korea but beyond one year in Japan. The associations observed were replicated in the validation cohort. Our findings contribute to the growing evidence base on long COVID by considering ethnic diversity.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kim</LastName><ForeName>Sunyoung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lee</LastName><ForeName>Hayeon</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0000-2403-6241</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Kyung Hee University, Yongin, South Korea. wwhy28@khu.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea. wwhy28@khu.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jinseok</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8580-490X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Kyung Hee University, Yongin, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung Won</ForeName><Initials>SW</Initials><Identifier Source="ORCID">0000-0001-5632-5208</Identifier><AffiliationInfo><Affiliation>Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Rosie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min Seo</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0003-2115-7835</Identifier><AffiliationInfo><Affiliation>Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koyanagi</LastName><ForeName>Ai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research and Development Unit, Parc Sanitari Sant Joan de Deu, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Lee</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5340-9833</Identifier><AffiliationInfo><Affiliation>Centre for Health, Performance and Wellbeing, Anglia Ruskin University, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fond</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3249-2030</Identifier><AffiliationInfo><Affiliation>Research Centre on Health Services and Quality of Life, Assistance Publique-H&#xf4;pitaux de Marseille, Aix Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyer</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Research Centre on Health Services and Quality of Life, Assistance Publique-H&#xf4;pitaux de Marseille, Aix Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahmati</LastName><ForeName>Masoud</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4792-027X</Identifier><AffiliationInfo><Affiliation>Research Centre on Health Services and Quality of Life, Assistance Publique-H&#xf4;pitaux de Marseille, Aix Marseille University, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Education and Sport Sciences, Faculty of Literature and Human Sciences, Lorestan University, Khoramabad, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Education and Sport Sciences, Faculty of Literature and Humanities, Vali-E-Asr University of Rafsanjan, Rafsanjan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez S&#xe1;nchez</LastName><ForeName>Guillermo F</ForeName><Initials>GF</Initials><Identifier Source="ORCID">0000-0002-9897-5273</Identifier><AffiliationInfo><Affiliation>Division of Preventive Medicine and Public Health, Department of Public Health Sciences, School of Medicine, University of Murcia, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dragioti</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pain and Rehabilitation Centre, and Department of Medical and Health Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Laboratory Psychology of Patients, Families and Health Professionals, Department of Nursing, School of Health Sciences, University of Ioannina, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortese</LastName><ForeName>Samuele</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Solent NHS Trust, Southampton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Child Study Center, Hassenfeld Children's Hospital at NYU Langone, NYU Langone, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Precision and Regenerative Medicine and Jonic Area, University of Bari 'Aldo Moro', Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Ju-Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Ahhyung</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Hae Sun</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Regulatory Science, Kyung Hee University Graduate School, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Regulatory Innovation through Science, Kyung Hee University College of Pharmacy, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sunmi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Applied Mathematics, Kyung Hee University, Yongin, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solmi</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4877-7233</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, SCIENCES lab, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>On Track: The Champlain First Episode Psychosis Program, Department of Mental Health, Ottawa Hospital, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute Clinical Epidemiology Program, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Child and Adolescent Psychiatry, Charit&#xe9; Universit&#xe4;tsmedizin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Chanyang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Jae Il</ForeName><Initials>JI</Initials><Identifier Source="ORCID">0000-0003-2326-1820</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea. SHINJI@yuhs.ac.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Severance Underwood Meta-Research Center, Institute of Convergence Science, Yonsei University, Seoul, South Korea. SHINJI@yuhs.ac.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yon</LastName><ForeName>Dong Keon</ForeName><Initials>DK</Initials><Identifier Source="ORCID">0000-0003-1628-9948</Identifier><AffiliationInfo><Affiliation>Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea. yonkkang@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Regulatory Science, Kyung Hee University Graduate School, Seoul, South Korea. yonkkang@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Regulatory Innovation through Science, Kyung Hee University College of Pharmacy, Seoul, South Korea. yonkkang@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea. yonkkang@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fusar-Poli</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Early Psychosis: Interventions and Clinical-Detection Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outreach and Support in South-London Service, South London and Maudlsey NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RS-2023-00248157</GrantID><Agency>National Research Foundation of Korea (NRF)</Agency><Country/></Grant><Grant><GrantID>HI22C1976</GrantID><Agency>Korea Health Industry Development Institute (KHIDI)</Agency><Country/></Grant><Grant><GrantID>21153MFDS601</GrantID><Agency>Ministry of Food and Drug Safety (MFDS)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Hum Behav</MedlineTA><NlmUniqueID>101697750</NlmUniqueID><ISSNLinking>2397-3374</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>25</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38918517</ArticleId><ArticleId IdType="doi">10.1038/s41562-024-01895-8</ArticleId><ArticleId IdType="pii">10.1038/s41562-024-01895-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Daugherty, S. E. et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. Br. Med. J. 373, n1098 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z., Xie, Y. &amp; Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259&#x2013;264 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha, Y., Jung, W., Seo, M. &amp; Rahmati, M. The emerging pandemic recent: SARS-CoV-2. Life Cycle 3, e2 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.54724/lc.2023.e2</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering, A. V., van Zon, S. K., Olde Hartman, T. C. &amp; Rosmalen, J. G. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 400, 452&#x2013;461 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35934007</ArticleId><ArticleId IdType="pmc">9352274</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Santomauro, D. F. et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 398, 1700&#x2013;1712 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02143-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet, M., Geddes, J. R., Husain, M., Luciano, S. &amp; Harrison, P. J. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8, 416&#x2013;427 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33836148</ArticleId><ArticleId IdType="pmc">8023694</ArticleId><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza, M. G. et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav. Immun. 89, 594&#x2013;600 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32738287</ArticleId><ArticleId IdType="pmc">7390748</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes, D. L. et al. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung 199, 113&#x2013;119 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33569660</ArticleId><ArticleId IdType="pmc">7875681</ArticleId><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, F., Liu, H.-l, Dai, N., Yang, M. &amp; Liu, J.-p A living systematic review of the psychological problems in people suffering from COVID-19. J. Affect. Disord. 292, 172&#x2013;188 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34126309</ArticleId><ArticleId IdType="pmc">8169237</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2021.05.060</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 398, 747&#x2013;758 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34454673</ArticleId><ArticleId IdType="pmc">8389999</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, C. J., Renshaw, P., Yurgelun-Todd, D. &amp; Sheth, C. Acute and chronic neuropsychiatric symptoms in novel coronavirus disease 2019 (COVID-19) patients: a qualitative review. Front. Public Health 10, 772335 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36033820</ArticleId><ArticleId IdType="pmc">9404694</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2022.772335</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch, J. B. et al. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun. 4, fcab297 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">35169700</ArticleId><ArticleId IdType="pmc">8833580</ArticleId><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, A. K. et al. Neuropsychiatric sequelae of long COVID-19: pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA. Brain Behav. Immun. Health 24, 100491 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35873350</ArticleId><ArticleId IdType="pmc">9290328</ArticleId><ArticleId IdType="doi">10.1016/j.bbih.2022.100491</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson, T. et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc. Health 6, 230&#x2013;239 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35143770</ArticleId><ArticleId IdType="pmc">8820961</ArticleId><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez, C. M. et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology 95, e1060&#x2013;e1070 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32482845</ArticleId><ArticleId IdType="pmc">7668545</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000009937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong, X. et al. Effect of psychological&#x2013;behavioral intervention on the depression and anxiety of COVID-19 patients. Front. Psychiatry 11, 586355 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33329130</ArticleId><ArticleId IdType="pmc">7715028</ArticleId><ArticleId IdType="doi">10.3389/fpsyt.2020.586355</ArticleId></ArticleIdList></Reference><Reference><Citation>Dravid, A. N., Mane, D. N. &amp; Khan, Z. A. Neurological issues during severe COVID-19 in a tertiary level hospital in Western India. Neurosci. Lett. 749, 135692 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33592305</ArticleId><ArticleId IdType="pmc">7881741</ArticleId><ArticleId IdType="doi">10.1016/j.neulet.2021.135692</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalleballe, K. et al. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav. Immun. 88, 71&#x2013;74 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32561222</ArticleId><ArticleId IdType="pmc">7297688</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2020.06.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte, K. I. et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine 53, 101624 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36051247</ArticleId><ArticleId IdType="pmc">9417563</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, E., Xie, Y. &amp; Al-Aly, Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 28, 2406&#x2013;2415 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36138154</ArticleId><ArticleId IdType="pmc">9671811</ArticleId><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Xu, E. &amp; Al-Aly, Z. Risks of mental health outcomes in people with COVID-19: cohort study. BMJ 376, e068993 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35172971</ArticleId><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou, S. H.-Y. et al. Global incidence of neurological manifestations among patients hospitalized with COVID-19&#x2014;a report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw. Open 4, e2112131 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33974053</ArticleId><ArticleId IdType="pmc">8114143</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn&#xfa;sd&#xf3;ttir, I. et al. Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study. Lancet Public Health 7, e406&#x2013;e416 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35298894</ArticleId><ArticleId IdType="pmc">8920517</ArticleId><ArticleId IdType="doi">10.1016/S2468-2667(22)00042-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet, M. et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1,284,437 patients. Lancet Psychiatry 9, 815&#x2013;827 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35987197</ArticleId><ArticleId IdType="pmc">9385200</ArticleId><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan, V., Christensen, R. H. B., Kondziella, D. &amp; Benros, M. E. COVID-19 and risk for mental disorders among adults in Denmark. JAMA Psychiatry 80, 778&#x2013;786 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37223890</ArticleId><ArticleId IdType="pmc">10209831</ArticleId><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.1265</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou, V. et al. Long COVID and neuropsychiatric manifestations (Review). Exp. Ther. Med. 23, 363 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35493431</ArticleId><ArticleId IdType="pmc">9019760</ArticleId><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, C.-W. et al. Anosmia and olfactory tract neuropathy in a case of COVID-19. J. Microbiol. Immunol. Infect. 54, 93&#x2013;96 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32576457</ArticleId><ArticleId IdType="doi">10.1016/j.jmii.2020.05.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Muus, C. et al. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat. Med. 27, 546&#x2013;559 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33654293</ArticleId><ArticleId IdType="pmc">9469728</ArticleId><ArticleId IdType="doi">10.1038/s41591-020-01227-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer, D. et al. COVID-19 and possible links with Parkinson&#x2019;s disease and parkinsonism: from bench to bedside. NPJ Parkinson&#x2019;s Dis. 6, 18 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-00123-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj, E. et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging 48, 2823&#x2013;2833 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33501506</ArticleId><ArticleId IdType="pmc">7837643</ArticleId><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes, E. A. et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 7, 547&#x2013;560 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32304649</ArticleId><ArticleId IdType="pmc">7159850</ArticleId><ArticleId IdType="doi">10.1016/S2215-0366(20)30168-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs, J. M. et al. The association between comorbid autism spectrum disorders and antipsychotic treatment failure in early-onset psychosis: a historical cohort study using electronic health records. J. Clin. Psychiatry 78, e1233&#x2013;e1241 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29125721</ArticleId><ArticleId IdType="pmc">6037287</ArticleId><ArticleId IdType="doi">10.4088/JCP.16m11422</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly, J. G., Thompson, K. &amp; Skedgel, C. The use of administrative health care databases to identify patients with rheumatoid arthritis. Open Access Rheumatol. Res. Rev. 7, 69&#x2013;75 (2015).</Citation></Reference><Reference><Citation>Mizrahi, B. et al. Long COVID outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 380, e072529 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36631153</ArticleId><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kj&#xf8;ller, K. et al. Connective tissue disease and other rheumatic conditions following cosmetic breast implantation in Denmark. Arch. Intern. Med. 161, 973&#x2013;979 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11295960</ArticleId><ArticleId IdType="doi">10.1001/archinte.161.7.973</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin, D. et al. Cost analysis of depression using the national insurance system in South Korea: a comparison of depression and treatment-resistant depression. BMC Health Serv. Res. 20, 286 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32252762</ArticleId><ArticleId IdType="pmc">7137426</ArticleId><ArticleId IdType="doi">10.1186/s12913-020-05153-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera, J. A. et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology 96, e575&#x2013;e586 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33020166</ArticleId><ArticleId IdType="pmc">7905791</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000011611</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S. W. et al. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study. Lancet Psychiatry 7, 1025&#x2013;1031 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32950066</ArticleId><ArticleId IdType="pmc">7498216</ArticleId><ArticleId IdType="doi">10.1016/S2215-0366(20)30421-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, M. S. et al. Long-term autoimmune inflammatory rheumatic outcomes of COVID-19: a binational cohort study. Ann. Intern. Med. 177, 291&#x2013;302 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38437702</ArticleId><ArticleId IdType="doi">10.7326/M23-1831</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, J. et al. Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK. Nat. Commun. 15, 2830 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38565542</ArticleId><ArticleId IdType="pmc">10987608</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-47176-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin, Y. H. et al. Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study. Lancet Rheumatol. 3, e698&#x2013;e706 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34179832</ArticleId><ArticleId IdType="pmc">8213376</ArticleId><ArticleId IdType="doi">10.1016/S2665-9913(21)00151-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, B., Sung, J., Park, K., Seo, S. &amp; Kim, S. Report of the Evaluation for Validity of Discharged Diagnoses in Korean Health Insurance Database 19&#x2013;52 (Seoul National University, 2003).</Citation></Reference><Reference><Citation>Lee, S. W. et al. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut 70, 76&#x2013;84 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32732368</ArticleId><ArticleId IdType="doi">10.1136/gutjnl-2020-322248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, B. H. et al. Clinical features of adult COVID-19 patients without risk factors before and after the nationwide SARS-CoV-2 B.1.617.2 (Delta)-variant outbreak in Korea: experience from Gyeongsangnam-do. J. Korean Med. Sci. 36, e341 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34931500</ArticleId><ArticleId IdType="pmc">8688347</ArticleId><ArticleId IdType="doi">10.3346/jkms.2021.36.e341</ArticleId></ArticleIdList></Reference><Reference><Citation>The Asia-Pacific Perspective: Redefining Obesity and Its Treatment (World Health Organization, 2000).</Citation></Reference><Reference><Citation>Lee, S. W. et al. Physical activity and the risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 related mortality in South Korea: a nationwide cohort study. Br. J. Sports Med. 56, 901&#x2013;912 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34301715</ArticleId><ArticleId IdType="doi">10.1136/bjsports-2021-104203</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich, M. R., Ikegami, N., Shibuya, K. &amp; Takemi, K. 50 years of pursuing a healthy society in Japan. Lancet 378, 1051&#x2013;1053 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21885101</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(11)60274-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Setogawa, N., Ohbe, H., Isogai, T., Matsui, H. &amp; Yasunaga, H. Characteristics and short-term outcomes of outpatient and inpatient cardiac catheterizations: a descriptive study using a nationwide claim database in Japan. J. Cardiol. 82, 201&#x2013;206 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37247658</ArticleId><ArticleId IdType="doi">10.1016/j.jjcc.2023.05.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko, H. et al. Medication-na&#xef;ve blood pressure and incident cancers: analysis of 2 nationwide population-based databases. Am. J. Hypertens. 35, 731&#x2013;739 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35512273</ArticleId><ArticleId IdType="doi">10.1093/ajh/hpac054</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson, C. W. et al. Competing risk analysis to address selection bias in comparative effectiveness research. Int. J. Radiat. Oncol. Biol. Phys. 108, S145&#x2013;S146 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijrobp.2020.07.890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S. W. Methods for testing statistical differences between groups in medical research: statistical standard and guideline of Life Cycle Committee. Life Cycle 2, e1 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.54724/lc.2022.e1</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>